Statistics for Efficacy and safety of vorapaxar with and without a thienopyridine for secondary prevention in patients with previous myocardial infarction and no history of stroke or transient ischemic attack : Results from TRA 2°P-TIMI 50
Total visits
| views | |
|---|---|
| Efficacy and safety of vorapaxar with and without a thienopyridine for secondary prevention in patients with previous myocardial infarction and no history of stroke or transient ischemic attack : Results from TRA 2°P-TIMI 50 | 57 |
Total visits per month
| views | |
|---|---|
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
File Visits
| views | |
|---|---|
| Efficacy and safety of vorapaxar with and without a thienopyridine for secondary prevention in patients with previous myocardial infarction and no history of.pdf | 64 |
Top country views
| views | |
|---|---|
| United States | 40 |
| Chile | 10 |
| Mexico | 1 |
Top city views
| views | |
|---|---|
| Miami | 36 |
| Santiago | 9 |
| Alameda | 2 |
| Campbell | 1 |
| Puerto Varas | 1 |
| Sacramento | 1 |
| Zapopan | 1 |